![](/img/cover-not-exists.png)
PCN195 COST COMPARISON BETWEEN LEUPROLIDE 3-MONTH FORMULATION AND GOSERELIN 1-MONTH FORMULATION AS ADJUVANT ENDOCRINE THERAPY IN POST-MASTECTOMY, PREMENOPAUSAL WOMEN WITH EARLY-STAGE, ESTROGEN RECEPTOR-POSITIVE BREAST CANCER WHO ARE AT MODERATE-TO-HIGH RISK OF RECURRENCE IN CHINA
Fan, L., Wang, Z., Yeh, Y.C., Du, F., Liu, G., Zheng, C., Zheng, L., Gao, X.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.391
Date:
November, 2019
File:
PDF, 650 KB
2019